<DOC>
	<DOCNO>NCT02226783</DOCNO>
	<brief_summary>Study evaluate effect intake food comparison fast condition pharmacodynamics AZD1722 follow twice-daily administration AZD1722 tablet formulation</brief_summary>
	<brief_title>D5611C00003 - Food Interaction Study With AZD1722 Tablet Healthy Subjects</brief_title>
	<detailed_description>A Phase I , Open-label , Randomized , Single-center , 3-way Crossover Study Healthy Subjects Evaluate Pharmacodynamics Effects AZD1722 Administered With Without Food ( Part A ) plus 2-way Crossover Subjects Evaluate Pharmacodynamic Effect AZD1722 Administered AZD1722 Free-base Tablet without Omeprazole ( Part B )</detailed_description>
	<mesh_term>Omeprazole</mesh_term>
	<criteria>1 . Healthy male female volunteer age 18 65 year 2 . Females childbearing potential negative pregnancy test female childbearing potential include study use 2 effective method avoid pregnancy , females nonchildbearing potential fulfill 1 follow criterion : 1 . Postmenopausal , define amenorrhea least 12 month follow cessation exogenous hormonal treatment luteinizing hormone ( LH ) folliclestimulating hormone ( FSH ) level postmenopausal range 2 . Documentation irreversible surgical sterilization hysterectomy , tubal occlusion , bilateral oophorectomy , bilateral salpingectomy tubal ligation 3 . Had body mass index ( BMI ) 18 30 kg/m2 , inclusive , weight least 50 kg 100 kg 4 . Regular bowel habit least 1 stool portion per day . ( 1 ) History clinicallysignificant disease disorder ( 2 ) History presence GI , hepatic , renal disease , include GI surgery , condition know interfere absorption , distribution , metabolism , excretion drug . ( 3 ) Any clinically significant illness , medical/surgical procedure , trauma within 4 week ( 4 ) clinicallysignificant abnormality clinical chemistry , hematology , urinalysis . ( 5 ) Abnormal vital sign 10minute supine rest , clinicallysignificant abnormality rhythm , conduction , morphology rest ECG ( 6 ) Prolonged QTcF great 450 m shorten QTcF le 340 m family history long QT syndrome . ( 7 ) Loose stool ( Bristol Stool Form Score [ BSFS ] 6 7 ) 2 day 7 day prior randomization ( 8 ) Use medication know affect stool consistency and/or GI motility , include fiber supplement , probiotic supplement , probiotic supplement medication form , antidiarrheal , prokinetic drug , enema , probiotic medication supplement ( ie , ActiviaÂ® ) ; salt electrolyte supplement contain sodium , potassium , chloride , bicarbonate formulation past 7 day randomization</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>Phase I</keyword>
	<keyword>Healthy subject</keyword>
	<keyword>PK</keyword>
	<keyword>PD</keyword>
</DOC>